{
    "eid": "2-s2.0-85132575575",
    "title": "ChAdOx1 nCoV-19 Immunogenicity and Immunological Response Following COVID-19 Infection in Patients Receiving Maintenance Hemodialysis",
    "cover-date": "2022-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "ChAdOx1 nCoV-19",
        "COVID-19",
        "ESRD",
        "hemodialysis",
        "immunogenicity",
        "post-infection",
        "SARS-CoV-2",
        "vaccines"
    ],
    "authors": [
        "Wisit Prasithsirikul",
        "Tanawin Nopsopon",
        "Phanupong Phutrakool",
        "Pawita Suwanwattana",
        "Piyawat Kantagowit",
        "Wannarat Pongpirul",
        "Anan Jongkaewwattana",
        "Krit Pongpirul"
    ],
    "citedby-count": 3,
    "ref-count": 65,
    "ref-list": [
        "A Novel Coronavirus from Patients with Pneumonia in China, 2019",
        "Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",
        "Kidney disease is associated with in-hospital death of patients with COVID-19",
        "Chronic kidney disease and acute kidney injury in the COVID-19 Spanish outbreak",
        "Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection",
        "Presentation and Outcomes of Patients with ESKD and COVID-19",
        "Excess Death Estimates in Patients with End-Stage Renal Disease\u2013United States, February\u2013August 2020",
        "Covid-19 in end-stage renal disease patients with renal replacement therapies: A systematic review and meta-analysis",
        "Coronavirus-associated kidney outcomes in COVID-19, SARS, and MERS: A meta-analysis and systematic review",
        "T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial",
        "Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: A preliminary report of a phase 1/2, single-blind, randomised controlled trial",
        "Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses",
        "Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): A single-blind, randomised, controlled, phase 2/3 trial",
        "Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK",
        "Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: A pooled analysis of four randomised trials",
        "Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): An exploratory analysis of a randomised controlled trial",
        "Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant",
        "Immune response to influenza vaccine in hemodialysis patients with chronic renal failure",
        "Influenza vaccine effectiveness in patients on hemodialysis: An analysis of a natural experiment",
        "Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients",
        "Incidence and Clinical Predictors of Nonresponse to Hepatitis B Vaccination among Patients Receiving Hemodialysis: Importance of Obesity",
        "Immunogenicity of 13-Valent Conjugate Pneumococcal Vaccine in Patients 50 Years and Older with End-Stage Renal Disease and on Dialysis",
        "Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis",
        "Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients",
        "Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis",
        "Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis",
        "Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: A single-arm substudy of a phase 2/3 clinical trial",
        "Humoral response to viral vector COVID-19 vaccine in hemodialysis patients",
        "Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: A call to arms",
        "Humoral Response to One and Two Doses of ChAdOx1-S Vaccine in Patients on Hemodialysis",
        "Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients: A multicenter prospective observational study",
        "Comparison of the immunogenicity of ChA-dOx1 nCoV-19 vaccine against the wild-type and delta variants in kidney transplant recipients and healthy volunteers",
        "Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age",
        "Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: An interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial",
        "Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan",
        "Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines",
        "Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients",
        "The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients",
        "Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients",
        "High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients",
        "Humoral response to BNT162b2 mRNA COVID-19 vaccine in peritoneal and hemodialysis patients: A comparative study",
        "Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis",
        "The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis",
        "Early Humoral Responses of Hemodialysis Patients after COVID-19 Vaccination with BNT162b2",
        "Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients",
        "Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared with healthy controls",
        "Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine",
        "SARS-CoV-2 mRNA Vaccine-Induced Cellular and Humoral Immunity in Hemodialysis Patients",
        "Short and mid-term SARS-CoV-2 antibody response after inactivated COVID-19 vaccine in hemodialysis and kidney transplant patients",
        "Immunogenicity of a first dose of mRNA-or vector-based SARS-CoV-2 vaccination in dialysis patients: A multicenter prospective observational pilot study",
        "Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection",
        "A Longitudinal, 3-Month Serologic Assessment of SARS-CoV-2 Infections in a Belgian Hemodialysis Facility",
        "SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects",
        "Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19",
        "Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: A longitudinal study",
        "Sequential Analysis of Binding and Neutralizing Antibody in COVID-19 Convalescent Patients at 14 Months After SARS-CoV-2 Infection",
        "Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects",
        "One-year sustained cellular and humoral immunities of COVID-19 convalescents",
        "SARS-CoV-2-specific Humoral and Cellular Immunities in Kidney Transplant Recipients and Dialyzed Patients Recovered From Severe and Nonsevere COVID-19",
        "Similar antibody responses against SARS-CoV-2 in HIV uninfected and infected individuals on antiretroviral therapy during the first South African infection wave",
        "Durability of the humoral immune response in recovered COVID-19 patients",
        "Differences in the Concentration of Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 Recovery or Post-Vaccination"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Boston",
            "@id": "60032499",
            "affilname": "Harvard T.H. Chan School of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032499",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60020543",
            "affilname": "Bumrungrad International Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020543",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pathum Thani",
            "@id": "60011947",
            "affilname": "Thailand National Center for Genetic Engineering and Biotechnology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011947",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Baltimore",
            "@id": "60006183",
            "affilname": "Johns Hopkins Bloomberg School of Public Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006183",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Nontaburi",
            "@id": "106545448",
            "affilname": "Bamrasnaradura Infectious Diseases Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/106545448",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Bamrasnaradura Infectious Diseases Institute",
        "Department of Disease Control",
        "Ministry of Public Health"
    ]
}